Panagora Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Hold |
116,099
| – | – | ﹤0.01% | 609 |
|
|
2025
Q1 | $629K | Buy |
116,099
+5,549
| +5% | +$30.1K | ﹤0.01% | 756 |
|
|
2024
Q4 | $824K | Sell |
110,550
-8,475
| -7% | -$63.1K | ﹤0.01% | 703 |
|
|
2024
Q3 | $951K | Sell |
119,025
-1,696
| -1% | -$13.6K | ﹤0.01% | 754 |
|
|
2024
Q2 | $1.05M | Buy |
120,721
+81,201
| +205% | +$706K | 0.01% | 711 |
|
|
2024
Q1 | $817K | Sell |
39,520
-41,260
| -51% | -$853K | ﹤0.01% | 858 |
|
|
2023
Q4 | $1.87M | Buy |
80,780
+5,541
| +7% | +$128K | 0.01% | 584 |
|
|
2023
Q3 | $601K | Hold |
75,239
| – | – | ﹤0.01% | 928 |
|
|
2023
Q2 | $655K | Buy |
75,239
+41,420
| +122% | +$360K | ﹤0.01% | 911 |
|
|
2023
Q1 | $99.4K | Buy |
33,819
+1,129
| +3% | +$3.32K | ﹤0.01% | 1417 |
|
|
2022
Q4 | $114K | Buy |
+32,690
| New | +$114K | ﹤0.01% | 1408 |
|
|
2020
Q3 | – | Sell |
-599
| Closed | -$5K | – | 2713 |
|
|
2020
Q2 | $5K | Hold |
599
| – | – | ﹤0.01% | 2344 |
|
|
2020
Q1 | $6K | Buy |
+599
| New | +$6K | ﹤0.01% | 2222 |
|
|
2018
Q4 | – | Sell |
-4,240
| Closed | -$151K | – | 2479 |
|
|
2018
Q3 | $151K | Sell |
4,240
-1,549
| -27% | -$55.2K | ﹤0.01% | 1757 |
|
|
2018
Q2 | $120K | Sell |
5,789
-6,914
| -54% | -$143K | ﹤0.01% | 1796 |
|
|
2018
Q1 | $155K | Hold |
12,703
| – | – | ﹤0.01% | 1740 |
|
|
2017
Q4 | $137K | Sell |
12,703
-1,082
| -8% | -$11.7K | ﹤0.01% | 1788 |
|
|
2017
Q3 | $165K | Buy |
+13,785
| New | +$165K | ﹤0.01% | 1756 |
|